Skip to main content
OpenTrials

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

228 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Completed

A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma

NCT00304525

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • University of Colorado Univ.ofColoradoCancerCenter Aurora, Colorado, United States
  • Georgia Regents University Cancer Clinical Research Unit Augusta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology Baltimore, Maryland, United States
  • Massachusetts General Hospital Dept of Cancer for Melanoma Boston, Massachusetts, United States
View Trial Details
Completed

Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors

NCT03326973

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma

NCT02177110

Conditions
Advanced Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations
  • Cork University Hospital Cork, Ireland
  • Beaumont Hosptial Dublin, Ireland
  • Mater Misericordiae University Hospital and Mater Private Hospital Dublin, Ireland
  • St Vincent's University Hospital Dublin, Ireland
View Trial Details
Completed

A Study of ASN007 in Patients With Advanced Solid Tumors

NCT03415126

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +51 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

NCT02158520

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +19 more
Locations
  • Saint Mary's Medical Center San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Illinois Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 13 locations
View Trial Details

Related conditions